Beijing Scitop Bio Tech Co Ltd
Beijing Scitop Bio-tech Co., Ltd. researches, develops, produces, and sells probiotic, postbiotics, and microecologival preparations for animals and plants in China. It provides probiotic and postbiotics for gastrointestinal health, immune regulation, oral health, sleep aid and stress relief, women's health, slimming and fat reduction, kidney and liver protection, blood sugar regulation, allergy … Read more
Market Cap & Net Worth: Beijing Scitop Bio Tech Co Ltd (300858)
Beijing Scitop Bio Tech Co Ltd (SHE:300858) has a market capitalization of $583.93 Million (CN¥4.28 Billion) as of March 18, 2026. Listed on the SHE stock exchange, this China-based company holds position #12730 globally and #3196 in its home market, demonstrating a -3.44% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Beijing Scitop Bio Tech Co Ltd's stock price CN¥16.26 by its total outstanding shares 263495118 (263.50 Million).
Beijing Scitop Bio Tech Co Ltd Market Cap History: 2020 to 2026
Beijing Scitop Bio Tech Co Ltd's market capitalization history from 2020 to 2026. Data shows growth from $757.82 Million to $583.93 Million (5.70% CAGR).
Beijing Scitop Bio Tech Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Beijing Scitop Bio Tech Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.71x
Beijing Scitop Bio Tech Co Ltd's market cap is 1.71 times its annual revenue
1728.56x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
5.47x
Beijing Scitop Bio Tech Co Ltd's market cap is 5.47 times its annual earnings
0.11x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $757.82 Million | $339.16 Million | $96.58 Million | 2.23x | 7.85x |
| 2021 | $757.85 Million | $364.62 Million | $109.54 Million | 2.08x | 6.92x |
| 2022 | $719.26 Million | $369.17 Million | $109.89 Million | 1.95x | 6.55x |
| 2023 | $686.05 Million | $299.24 Million | $93.48 Million | 2.29x | 7.34x |
| 2024 | $516.41 Million | $302.79 Million | $94.36 Million | 1.71x | 5.47x |
Competitor Companies of 300858 by Market Capitalization
Companies near Beijing Scitop Bio Tech Co Ltd in the global market cap rankings as of March 18, 2026.
Key companies related to Beijing Scitop Bio Tech Co Ltd by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Beijing Scitop Bio Tech Co Ltd Historical Marketcap From 2020 to 2026
Between 2020 and today, Beijing Scitop Bio Tech Co Ltd's market cap moved from $757.82 Million to $ 583.93 Million, with a yearly change of 5.70%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥583.93 Million | -3.04% |
| 2025 | CN¥602.24 Million | +16.62% |
| 2024 | CN¥516.41 Million | -24.73% |
| 2023 | CN¥686.05 Million | -4.62% |
| 2022 | CN¥719.26 Million | -5.09% |
| 2021 | CN¥757.85 Million | 0.00% |
| 2020 | CN¥757.82 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Beijing Scitop Bio Tech Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $583.93 Million USD |
| MoneyControl | $583.93 Million USD |
| MarketWatch | $583.93 Million USD |
| marketcap.company | $583.93 Million USD |
| Reuters | $583.93 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.